Iksuda Therapeutics Email Format

Biotechnology ResearchTyne and Wear, United Kingdom11-50 Employees

Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers.

Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. 

All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety. 

✕

Access Insights for Iksuda Therapeutics and Millions of Other Companies

Sign up for full access to Iksuda Therapeutics information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory